U.S. Markets close in 2 hrs 20 mins

ImmuCell Corporation (ICCC)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
6.60+0.16 (+2.48%)
As of 1:36PM EDT. Market open.
People also watch
HSKAHMGNCYANNYMXIRIX

ImmuCell Corporation

56 Evergreen Drive
Portland, ME 04103
United States
207-878-2770
http://www.immucell.com

SectorHealthcare
IndustryBiotechnology
Full Time Employees40

Key Executives

NameTitlePayExercisedAge
Mr. Michael F. BrighamChief Exec. Officer, Pres, Chief Financial Officer, Treasurer, Sec. and Director310.75kN/A56
Dr. Joseph H. Crabb Ph.D.Chief Scientific Officer, VP and Director56.8kN/A62
Ms. Bobbi Jo BrockmannVP of Sales & Marketing and Director216.22kN/A40
Ms. Elizabeth L. WilliamsVP of Manufacturing Operations199.68kN/A61
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

ImmuCell Corporation develops, acquires, manufactures, and sells products that enhance animal health and productivity of cows for the dairy and beef industries in the United States and internationally. The company offers First Defense, an orally delivered scours preventive product for calves; Wipe Out Dairy Wipes, which consist of towelettes that are pre-moistened with a Nisin-based formulation to prepare the teat area of a cow in advance of milking; and California Mastitis Test that could be used for bulk tank and individual cow sample monitoring, as well as to determine which quarter of the udder is mastitic. It is also involved in the development of Mast Out, a Nisin-based treatment of subclinical mastitis in lactating dairy cows; and treatments that prevent E. coli K99 and bovine coronavirus, as well as calf scours caused by enteric pathogens. In addition, the company sells various product applications of its First Defense Technology, including a whey protein concentrate for the nutritional and feed supplement markets. ImmuCell Corporation sells its products to distributors and bovine veterinarians, as well as directly to producers. The company was founded in 1982 and is based in Portland, Maine.

Corporate Governance

ImmuCell Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.